Viome - About the company
Viome is a series D company based in Bellevue (United States), founded in 2016 by Deepak Savadatti and Naveen Jain. It operates as a Provider of a machine learning based bioinformatics solutions. Viome has raised $292M in funding from investors like Khosla Ventures, Physician Partners and Bold Capital Partners, with a current valuation of $*****. The company has 11 active competitors, including 4 that are funded. Its top competitors include companies like Evvy, Flore and MoldCo.
Company Details
Provider of machine learning-based bioinformatics solutions. It uses bioinformatics and machine learning to provide deep insights into users' or customers' health and well-being. It helps in providing meaningful insights from this data to inform users on how to change their behavior and diet to live healthier lives. It also offers a kit "Gut Intelligence" for providing gut microbiome tests.
- Website
- www.viome.com
- Social
Key Metrics
Founded Year
2016
Location
Bellevue, United States
Stage
Series D
Total Funding
$292M in 9 rounds
Latest Funding Round
Post Money Valuation
$***** as on Aug 18, 2023
Investors
Ranked
1st among 11 active competitors
Employee Count
99 as on Sep 30, 2026
Investment & Acquisitions
Legal entities associated with Viome
Viome is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Viome Life Sciences, Inc CIN: 81-3161987 , United States, Active | Dec 31, 2015 | - | - | - |
Viome Life Sciences, Inc. CIN: 813161987 , United States, Active | Dec 31, 1999 | - | 58 (As on Dec 31, 2024) | - |
Sign up to download Viome's company profile
Viome's funding and investors
Viome has raised a total funding of $292M over 9 rounds. Its latest funding round was a Series D round on Sep 09, 2024 for $*****. 4 investors participated in its latest round. Viome has 16 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Viome:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 09, 2024 | 9380287 | Series D | 3847844 | 9608526 | 3620904 | 3236414 |
Aug 18, 2023 | 8023324 | Series C | 2072025 | 1784825 | 8320115 | |
Oct 11, 2022 | 2310845 | Series C | 5692268 | 4034824 |
Access funding benchmarks and valuations. Sign up today!View details of Viome's funding rounds and investors
Viome's founders and board of directors
Founder? Claim ProfileThe founders of Viome are Deepak Savadatti and Naveen Jain.
Here are the details of Viome's key team members:
- Deepak Savadatti: Co-Founder of Viome and founder of 1 other company. They serve on the board of 1 company.Contact Info: 1 email address
- Naveen Jain: Co-Founder & CEO of Viome and founder of 2 other companies, Viome Life Sciences and Blue Tech. Contact Info: 2 email addresses
View details of Viome's Founder profiles and Board Members
Viome's employee count trend
Viome has 99 employees as of Sep 26. Here is Viome's employee count trend over the years:
Uncover Viome's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Viome's Competitors and alternates
Top competitors of Viome include Evvy, Flore and MoldCo. Here is the list of Top 10 competitors of Viome, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Viome 2016, Bellevue (United States), Series D | Provider of a machine learning based bioinformatics solutions | $292M | 73/100 | |
2nd |  Evvy 2002, New York City (United States), Series B | Online platform providing test kits for microbiome analysis | $59M | 58/100 | |
3rd |  Flore 2016, San Diego (United States), Series A | Provide nutritional supplements to improve gut health | $21.1M | 49/100 | |
4th | MoldCo 1987, Boston (United States), Seed | Provider of telehealth care, lab testing, and mold exposure recovery programs | $11M | 47/100 | |
5th | uBiome 2012, San Francisco (United States), Deadpooled | Provider of sequence dataset of human microbiome | $110M | 44/100 | |
6th |  Jona 2022, Hialeah (United States), Funding Raised | AI-powered microbiome profiling platform to improve digestive health | - | 32/100 | |
7th |  Kean Health 2004, Sterling (United States), Unfunded | Provider of the gut microbiome and gene test kits | - | - | 28/100 |
8th | HelloBiome 2022, San Francisco (United States), Unfunded | AI-powered microbiome testing platform for personalized recommendations | - | - | 28/100 |
9th |  HyperSpectral 2020, United States, Unfunded | Provider of an internet first based diagnostic services | - | - | 27/100 |
10th |  Anteros Bio 2022, Boston (United States), Unfunded | Provider of at-home genital microbiome tests for couples | - | - | 26/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Viome's competitors? Click here to see the top ones
Viome's Investments and acquisitions
Viome has not made any investments yet. Viome has made 4 acquisitions.Here is the list of latest three $acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 01, 2026 | Acquisition | 2024 | Waltham (United States) | |
Aug 12, 2026 | Acquisition | 2021 | Seattle (United States) | |
Nov 02, 2023 | Acquisition | 2022 | Palo Alto (United States) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Viome
Reports related to Viome
Here is the latest report on Viome's sector:
News related to Viome
Filter this listMedia has covered Viome for a total of 4 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
Viome PRO Introduces Blood Test for Pancreatic Cancer DetectionHospital Management•Oct 09, 2026•Viome
•
Viome Acquires Sōlaria Bio to Launch Clinically Validated Consumer Synbiotics and Medical FoodsBusiness Wire•Oct 01, 2026•Viome
•
Viome Partners with Japan's Ezaki Glico to Bring Precision Health Intelligence to JapanBusiness Wire•Sep 14, 2026•Viome
•
•
Viome Raises $25M To Launch Diagnostics DivisionHIT Consultant•Sep 10, 2024•Viome, Khosla Ventures, Bold Capital Partners, CVS pharmacy
•
Wellness startup Viome targets oral health with toothpaste and gel formulated via microbiome dataGeekWire•Jul 17, 2024•Viome
•
•
Viome Launches Clinically Validated Oral Health and Early Stage Cancer Detection Test For Dental ProfessionalsBusiness Wire•Sep 28, 2023•Viome
•
Viome, a microbiome startup, raises $86.5M, inks distribution deal with CVSTechCrunch+•Aug 18, 2023•Viome, Khosla Ventures, Bold Capital Partners, WestRiver Group and 1 other
•
Viome Life Sciences raises $54M for expanded clinical trialsMobiHealthNews•Nov 10, 2021•Viome, Khosla Ventures, WestRiver Group, Glico Group and 5 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Viome
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
